Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 348
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Down Low: Curbing the HIV Epidemic in Rural Louisiana

    African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

    Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

    Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

    What is the role of the CLN1-CDK1 complex in the cell regulatory cycle of baker's yeast?

    In Saccharomyces cerevisiae, the protein CLN1 forms a complex with the CDK1 in the cell regulatory cycle. Studies...

    Backer Badge Funded